出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年7月
メタゲノムシーケンシング市場 : 製品＆サービス (試薬、消耗品、機器)、ワークフロー (サンプル調製、シーケンス)、テクノロジー (16S rRNA、ショットガン、全ゲノム)、用途 (創薬、診断、産業) – 2028年までの世界予測
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) – Global Forecast to 2028
| ページ数 | 257 |
| 図表数 | 270 |
| 種別 | 英文調査報告書 |
| 価格 |
The global metagenomic sequencing market is projected to reach USD 4.5 million by 2028 from USD 2.0 billion in 2023, at a CAGR of 17.5%. The key factors driving the growth of the metagenomic sequencing market are the continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing. However, funding and budget constraint in developing countries is expected to restrain market growth to a certain extent.
The metagenomic sequencing market has been segmented based on product & service, workflow, technology, application and region.
“By technology, the Shotgun Metagenomic Sequencing segment accounted for the second largest share of the metagenomic sequencing market”
Based on technology, the metagenomic sequencing market is categorized into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. The Shotgun Metagenomic Sequencing segment accounted for the second largest share of the market in 2022, owing to the advantages that it offers and growing adoption of this technology.
“By applications, the drug discovery accounted for the largest share in the metagenomic sequencing market”
Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. In 2022, the drug discovery segment accounted for a largest share of the metagenomic sequencing market. Growth in this market segment can be attributed to one of the major factors which is the increasing research activities for new drugs.
“North America: the largest share of the metagenomic sequencing market”
North America accounted for the largest share of the metagenomic sequencing market. The large share of the North America region can be attributed to major factors such as support from the government and private agencies terms of funding for adoption of NGS based metagenomic technologies, increase in the number of NGS based metagenomics activities as well as a strong presence of the key market players in the region.
“Asia Pacific: The fastest-growing region in the metagenomic sequencing market.”
The Asia Pacific metagenomic sequencing market is projected to grow at the highest CAGR during the forecast period. This is attributed to one of the major factors including the increasing support from public as well as private agencies in terms of funding. Also, there has been an increase in the number of NGS-based research projects in the region which is also expected to support the market growth.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, Directors- 30%, and Executives – 25%
• By Country: North America- 25%, Europe- 25%, Asia Pacific- 40%, Latin America- 5%, and Middle East & Africa- 5%
Prominent Players
• Illumina, Inc. (US)
• Thermo Fisher Scientific, Inc. (US)
• PerkinElmer, Inc. (US)
• QIAGEN N.V. (Netherlands)
• Oxford Nanopore Technologies, Plc. (UK)
• Pacific Biosciences of California, Inc. (US)
• BGI Group (China)
• Psomagen, Inc. (US)
• Eurofins Scientific, (Luxembourg)
• Azenta, Inc. (US)
• Novogene Co., Ltd. (China)
• Zymo Research Corporation (US)
• Tecan Trading AG (Switzerland)
• Integragen SA (France)
• Microsynth AG (Switzerland)
• DNAStar, Inc. (US)
• CosmosID, Inc. (US)
• MedGenome (US)
• Terra Bioforge (US)
• Veritas Genetics (US)
• BaseClear B.V. (Netherlands)
• Metagenomi (US)
• Computomics (Germany)
• New England Biolabs (US)
• Intact Genomics, Inc. (US)
Research Coverage:
This report provides a detailed picture of the metagenomic sequencing market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & service, workflow, technology, application and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the metagenomic sequencing market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provide insights on the following pointers”
• Analysis of key drivers (frequent innovations in technology of NGS platforms), opportunities (big data application in NGS), restraint (budget constraints in developing economies) and challenges (challenges associated with metagenomics NGS) influencing the growth of the metagenomic sequencing market.
• Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the metagenomic sequencing market.
• Market Development: Comprehensive information about lucrative markets- the report analyses the metagenomic sequencing market across varied regions.
• Market Diversification: Exhaustive information about new products and service, untapped geographies, recent developments, and investments in the metagenomic sequencing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product and service offerings of leading players like Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK) among others in the metagenomic sequencing market.
目次
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
FIGURE 1 METAGENOMIC SEQUENCING MARKET SEGMENTATION 33
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY 34
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 35
1.7.1 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
FIGURE 3 METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES 38
2.1.2.1 Key industry insights 39
2.2 MARKET ESTIMATION 40
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2022 40
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING PRODUCTS & SERVICES 41
FIGURE 6 METAGENOMIC SEQUENCING MARKET: MARKET SIZE ESTIMATION APPROACHES 41
2.3 GROWTH FORECAST 43
FIGURE 7 METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2023–2028 43
FIGURE 8 METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 9 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH LIMITATIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 47
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 47
3 EXECUTIVE SUMMARY 49
FIGURE 10 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 11 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2023 VS. 2028 (USD MILLION) 50
FIGURE 12 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 50
FIGURE 13 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 51
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF METAGENOMIC SEQUENCING MARKET 52
4 PREMIUM INSIGHTS 53
4.1 METAGENOMIC SEQUENCING MARKET OVERVIEW 53
FIGURE 15 TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS TO DRIVE GROWTH IN METAGENOMIC SEQUENCING MARKET 53
4.2 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY & COUNTRY (2022) 54
FIGURE 16 16S RRNA SEQUENCING TECHNOLOGY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 54
4.3 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2022 55
FIGURE 17 SAMPLE PROCESSING & LIBRARY PREPARATION SEGMENT DOMINATED MARKET IN 2022 55
4.4 METAGENOMIC SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 19 METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Continuous technological innovations in NGS platforms 58
5.2.1.1.1 Ion Torrent Genexus Dx Integrated Sequencer 58
5.2.1.1.2 iSeq 100 System 58
5.2.1.1.3 Ion GeneStudio S5 58
5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects 59
TABLE 2 GLOBAL SEQUENCING INITIATIVES 59
5.2.1.3 Declining cost of genome sequencing 60
FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2021 60
5.2.1.4 Significant applications of metagenomics in various fields 60
5.2.2 RESTRAINTS 61
5.2.2.1 End-user budget constraints in developing countries 61
5.2.2.2 Stagnation in NGS product market in developed countries 62
5.2.3 OPPORTUNITIES 62
5.2.3.1 NGS data analysis using big data 62
5.2.4 CHALLENGES 63
5.2.4.1 Challenges associated with metagenomic NGS 63
5.3 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 3 METAGENOMIC SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.3.1 THREAT OF NEW ENTRANTS 63
5.3.2 THREAT OF SUBSTITUTES 64
5.3.3 BARGAINING POWER OF SUPPLIERS 64
5.3.4 BARGAINING POWER OF BUYERS 64
5.3.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 64
5.4 VALUE CHAIN ANALYSIS 64
FIGURE 21 VALUE CHAIN ANALYSIS OF METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE 64
FIGURE 22 VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW—MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES 65
5.5 ECOSYSTEM ANALYSIS 66
FIGURE 23 ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET 66
TABLE 4 SUPPLY CHAIN ECOSYSTEM 66
5.6 PATENT ANALYSIS 68
FIGURE 24 PATENT APPLICATIONS FOR METAGENOMIC SEQUENCING PRODUCTS, JANUARY 2012–JUNE 2023 68
TABLE 5 INDICATIVE LIST OF PATENTS IN METAGENOMIC SEQUENCING MARKET 69
5.7 SUPPLY CHAIN ANALYSIS 70
FIGURE 25 METAGENOMIC SEQUENCING MARKET: SUPPLY CHAIN ANALYSIS 71
5.8 REGULATORY ANALYSIS 71
5.8.1 NORTH AMERICA 71
5.8.1.1 US 71
TABLE 6 US FDA: CLASSIFICATION OF MEDICAL DEVICES 72
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
5.8.1.2 Canada 73
5.8.2 EUROPE 73
5.8.3 ASIA PACIFIC 74
5.8.3.1 China 74
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
5.8.3.2 Japan 75
5.8.3.3 India 75
5.8.4 LATIN AMERICA 75
5.8.5 MIDDLE EAST 75
5.9 PRICING ANALYSIS 76
5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS 76
TABLE 9 AVERAGE SELLING PRICE OF NGS SYSTEMS (2021) 76
5.10 TRADE ANALYSIS 76
5.10.1 TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET 76
TABLE 10 IMPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016–2020 (USD THOUSAND) 76
TABLE 11 EXPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016–2020 (USD THOUSAND) 77
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.12 KEY CONFERENCES & EVENTS, 2023–2024 78
TABLE 12 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS 78
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 79
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF METAGENOMIC SEQUENCING PRODUCTS & SERVICES IN RESEARCH & ACADEMIC INSTITUTES 79
5.13.2 BUYING CRITERIA FOR METAGENOMIC SEQUENCING MARKET 79
FIGURE 27 KEY BUYING CRITERIA FOR RESEARCH & ACADEMIC INSTITUTES 79
6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE 80
6.1 INTRODUCTION 81
TABLE 13 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 81
6.2 REAGENTS & CONSUMABLES 81
6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING TO DRIVE ADOPTION OF REAGENTS & CONSUMABLES 81
TABLE 14 METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 15 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 16 EUROPE: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 17 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.3 INSTRUMENTS 83
6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS TO SUPPORT GROWTH 83
TABLE 18 METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 19 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 20 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 21 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.4 SEQUENCING SERVICES 86
6.4.1 COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS TO BOOST DEMAND FOR SERVICES 86
TABLE 22 METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 23 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 24 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 25 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.5 ANALYSIS & DATA INTERPRETATION SOLUTIONS 88
6.5.1 AVAILABILITY OF WIDE RANGE OF SOLUTIONS TO SUPPORT MARKET GROWTH 88
TABLE 26 METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 27 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 28 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 29 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 89
7 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY 90
7.1 INTRODUCTION 91
TABLE 30 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 91
7.2 16S RRNA SEQUENCING 91
7.2.1 COST-EFFECTIVE TECHNIQUE FOR IDENTIFICATION OF BACTERIAL STRAINS TO DRIVE DEMAND 91
TABLE 31 16S RRNA SEQUENCING MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 32 NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 33 EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 34 ASIA PACIFIC: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
7.3 SHOTGUN METAGENOMIC SEQUENCING 93
7.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 93
TABLE 35 SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 36 NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 37 EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 38 ASIA PACIFIC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.4 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY 96
7.4.1 ABILITY OF WGS TO SEQUENCE COMPLETE METAGENOME OF ENVIRONMENTAL SAMPLES TO BOOST ADOPTION 96
TABLE 39 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 40 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 41 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 42 ASIA PACIFIC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
7.5 METATRANSCRIPTOMICS 98
7.5.1 ABILITY OF METATRANSCRIPTOMICS TO STUDY ACTIVE FUNCTIONAL PROFILE OF MICROBIAL COMMUNITY TO FUEL GROWTH 98
TABLE 43 METATRANSCRIPTOMICS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 44 NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 45 EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 46 ASIA PACIFIC: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
8 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW 101
8.1 INTRODUCTION 102
TABLE 47 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 102
8.2 SAMPLE PROCESSING & LIBRARY PREPARATION 102
8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS TO DRIVE MARKET GROWTH 102
TABLE 48 METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 49 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 50 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 51 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.3 SEQUENCING 104
8.3.1 GROWING PREFERENCE FOR SANGER SEQUENCING OVER NGS DUE TO ITS ADVANTAGES AND RAPIDITY TO BOOST MARKET 104
TABLE 52 METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 53 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 54 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 55 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.4 DATA PROCESSING & ANALYSIS 107
8.4.1 TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF BROAD RANGE OF TOOLS TO SUPPORT MARKET GROWTH 107
TABLE 56 METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 57 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 58 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 59 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 108
9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION 109
9.1 INTRODUCTION 110
TABLE 60 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
9.2 DRUG DISCOVERY 110
9.2.1 DRUG DISCOVERY APPLICATIONS TO ACCOUNT FOR LARGEST SHARE OF METAGENOMIC SEQUENCING MARKET DURING FORECAST PERIOD 110
TABLE 61 METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 62 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 63 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 64 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 112
9.3 CLINICAL DIAGNOSTICS 113
9.3.1 ADVANTAGES OF METAGENOMIC NGS TO INCREASE APPLICATIONS IN DIAGNOSTICS 113
TABLE 65 METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 66 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 67 EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 68 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.4 SOIL MICROBIOME APPLICATIONS 115
9.4.1 NORTH AMERICA TO REGISTER HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS 115
TABLE 69 METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 70 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 71 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 72 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
9.5 INDUSTRIAL APPLICATIONS 117
TABLE 73 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 74 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 75 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 76 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 77 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 118
9.5.1 ENERGY 119
9.5.1.1 Declining fossil fuel reserves and growing energy needs to drive demand 119
TABLE 78 METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 79 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 80 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 81 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.5.2 BIOREMEDIATION 120
9.5.2.1 Need to monitor pollutant impact and contamination to provide opportunities for metagenomic sequencing in bioremediation 120
TABLE 82 METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 83 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 84 EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 85 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5.3 OTHER INDUSTRIAL APPLICATIONS 122
TABLE 86 METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 87 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 88 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 89 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
9.6 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS 124
9.6.1 ABILITY OF METAGENOMIC SEQUENCING TO IDENTIFY INVASIVE AND ENDANGERED SPECIES TO BOOST ADOPTION 124
TABLE 90 METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 91 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 92 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 93 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
9.7 VETERINARY APPLICATIONS 126
9.7.1 GROWING DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS TO SUPPORT MARKET GROWTH 126
TABLE 94 METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 95 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 96 EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 97 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 127
9.8 OTHER APPLICATIONS 128
TABLE 98 METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 99 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 100 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 101 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
10 METAGENOMIC SEQUENCING MARKET, BY REGION 130
10.1 INTRODUCTION 131
TABLE 102 METAGENOMIC SEQUENCING MARKET, BY REGION, 2021–2028 (USD MILLION) 131
10.2 NORTH AMERICA 132
FIGURE 28 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT 132
TABLE 103 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 104 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 133
TABLE 105 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 133
TABLE 106 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
TABLE 107 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 108 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 135
10.2.1 US 135
10.2.1.1 Well-established infrastructure and availability of funding to drive market growth 135
TABLE 109 US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 136
TABLE 110 US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 136
TABLE 111 US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 112 US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 113 US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 138
10.2.2 CANADA 138
10.2.2.1 Increasing government initiatives and workshops to support growth 138
TABLE 114 CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 139
TABLE 115 CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139
TABLE 116 CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 117 CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 140
TABLE 118 CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141
10.2.3 NORTH AMERICA: RECESSION IMPACT 141
10.3 EUROPE 142
TABLE 119 EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 120 EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 142
TABLE 121 EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 143
TABLE 122 EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 123 EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 124 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 144
10.3.1 GERMANY 145
10.3.1.1 Growing investments in next-generation technologies to boost market 145
TABLE 125 GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 145
TABLE 126 GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 146
TABLE 127 GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 146
TABLE 128 GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 129 GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 147
10.3.2 FRANCE 148
10.3.2.1 Government initiatives to support genomics research to drive growth 148
TABLE 130 FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 148
TABLE 131 FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 149
TABLE 132 FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 149
TABLE 133 FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 134 FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150
10.3.3 UK 151
10.3.3.1 Favorable funding scenario for genomics research to support adoption of NGS 151
TABLE 135 UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 151
TABLE 136 UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 152
TABLE 137 UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 138 UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 139 UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153
10.3.4 REST OF EUROPE 154
TABLE 140 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 154
TABLE 141 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 155
TABLE 142 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 143 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 144 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 156
10.3.5 EUROPE: RECESSION IMPACT 157
10.4 ASIA PACIFIC 157
FIGURE 29 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT 158
TABLE 145 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 146 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 159
TABLE 147 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 160
TABLE 148 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 160
TABLE 149 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 150 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 161
10.4.1 CHINA 162
10.4.1.1 Increasing focus of key market players on strengthening their presence and offerings in China to drive market growth 162
TABLE 151 CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 163
TABLE 152 CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 163
TABLE 153 CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 164
TABLE 154 CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 155 CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 165
10.4.2 JAPAN 165
10.4.2.1 Rising use of metagenomic sequencing for various applications to drive market growth in Japan 165
TABLE 156 JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 166
TABLE 157 JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 166
TABLE 158 JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 159 JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 160 JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168
10.4.3 INDIA 168
10.4.3.1 Increasing collaborations and partnerships by various private and government bodies to drive market growth 168
TABLE 161 INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 169
TABLE 162 INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 163 INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 170
TABLE 164 INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 165 INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171
10.4.4 REST OF ASIA PACIFIC 171
TABLE 166 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 172
TABLE 167 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 168 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 173
TABLE 169 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 170 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 174
10.4.5 ASIA PACIFIC: RECESSION IMPACT 174
10.5 LATIN AMERICA 175
10.5.1 INTRODUCTION OF LOW-COST SEQUENCING TECHNOLOGIES TO DRIVE MARKET 175
TABLE 171 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 175
TABLE 172 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 176
TABLE 173 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 176
TABLE 174 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 175 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
10.5.2 LATIN AMERICA: RECESSION IMPACT 178
10.6 MIDDLE EAST & AFRICA 178
10.6.1 RISING AWARENESS OF ADVANCED SEQUENCING TECHNOLOGIES TO DRIVE MARKET GROWTH IN COMING YEARS 178
TABLE 176 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 178
TABLE 177 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 178 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 179 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
TABLE 180 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 180
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 181
11 COMPETITIVE LANDSCAPE 182
11.1 KEY PLAYER STRATEGIES 182
FIGURE 30 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN METAGENOMIC SEQUENCING MARKET 183
11.2 MARKET SHARE ANALYSIS 184
FIGURE 31 METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 184
TABLE 181 METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION 184
11.3 REVENUE ANALYSIS 185
FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022) 185
11.4 COMPANY EVALUATION QUADRANT (2022) 186
11.4.1 STARS 186
11.4.2 PERVASIVE PLAYERS 186
11.4.3 EMERGING LEADERS 186
11.4.4 PARTICIPANTS 186
FIGURE 33 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2022 187
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2022) 188
11.5.1 PROGRESSIVE COMPANIES 188
11.5.2 STARTING BLOCKS 188
11.5.3 DYNAMIC COMPANIES 188
11.5.4 RESPONSIVE COMPANIES 188
FIGURE 34 COMPANY EVALUATION MATRIX FOR START-UPS, 2022 189
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 190
11.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 190
TABLE 182 COMPANY FOOTPRINT ANALYSIS, BY PRODUCT & SERVICE 190
11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 191
TABLE 183 COMPANY FOOTPRINT, BY REGION 191
11.7 COMPETITIVE BENCHMARKING OF START-UPS/SMES 192
TABLE 184 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES 192
TABLE 185 METAGENOMIC SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 193
11.8 COMPETITIVE SCENARIO 193
11.8.1 PRODUCT LAUNCHES 193
TABLE 186 METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 193
11.8.2 DEALS 194
TABLE 187 METAGENOMIC SEQUENCING MARKET: DEALS, JANUARY 2020–JUNE 2023 194
11.8.3 OTHER DEVELOPMENTS 195
TABLE 188 METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–FEBRUARY 2023 195
12 COMPANY PROFILES 196
12.1 MAJOR PLAYERS 196
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 ILLUMINA, INC. 196
TABLE 189 ILLUMINA, INC.: BUSINESS OVERVIEW 196
FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) 197
TABLE 190 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS 199
TABLE 191 ILLUMINA, INC.: DEALS 200
TABLE 192 ILLUMINA, INC.: OTHER DEVELOPMENTS 202
12.1.2 THERMO FISHER SCIENTIFIC, INC. 203
TABLE 193 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 203
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 204
TABLE 194 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES 206
TABLE 195 THERMO FISHER SCIENTIFIC, INC.: DEALS 207
12.1.3 PERKINELMER, INC. 209
TABLE 196 PERKINELMER, INC.: BUSINESS OVERVIEW 209
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 210
TABLE 197 PERKINELMER, INC.: PRODUCT LAUNCHES 211
TABLE 198 PERKINELMER, INC.: DEALS 212
12.1.4 QIAGEN N.V. 212
TABLE 199 QIAGEN N.V.: BUSINESS OVERVIEW 213
FIGURE 38 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 214
TABLE 200 QIAGEN N.V.: PRODUCT LAUNCHES 216
TABLE 201 QIAGEN N.V.: DEALS 216
TABLE 202 QIAGEN N.V.: OTHER DEVELOPMENTS 217
12.1.5 OXFORD NANOPORE TECHNOLOGIES, PLC 218
TABLE 203 OXFORD NANOPORE TECHNOLOGIES, PLC: BUSINESS OVERVIEW 218
FIGURE 39 OXFORD NANOPORE TECHNOLOGIES, PLC: COMPANY SNAPSHOT (2022) 219
TABLE 204 OXFORD NANOPORE TECHNOLOGIES, PLC: PRODUCT LAUNCHES 220
TABLE 205 OXFORD NANOPORE TECHNOLOGIES, PLC: DEALS 221
12.1.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 223
TABLE 206 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW 223
FIGURE 40 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2022) 224
TABLE 207 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: PRODUCT LAUNCHES 226
TABLE 208 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: DEALS 226
12.1.7 BGI GROUP 228
TABLE 209 BGI GROUP: BUSINESS OVERVIEW 228
TABLE 210 BGI GROUP: PRODUCT LAUNCHES 230
TABLE 211 BGI GROUP: DEALS 230
12.1.8 PSOMAGEN, INC. 231
TABLE 212 PSOMAGEN, INC.: BUSINESS OVERVIEW 231
TABLE 213 PSOMAGEN, INC.: DEALS 232
12.1.9 EUROFINS SCIENTIFIC 233
TABLE 214 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 233
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 234
12.1.10 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.) 236
TABLE 215 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.): BUSINESS OVERVIEW 236
FIGURE 42 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.): COMPANY SNAPSHOT (2022) 237
12.1.11 NOVOGENE CO., LTD. 239
TABLE 216 NOVOGENE CO., LTD.: BUSINESS OVERVIEW 239
TABLE 217 NOVOGENE CO., LTD.: SERVICE LAUNCHES 240
TABLE 218 NOVOGENE CO., LTD.: DEALS 240
12.1.12 ZYMO RESEARCH CORPORATION 241
TABLE 219 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW 241
TABLE 220 ZYMO RESEARCH CORPORATION: SERVICE LAUNCHES 242
TABLE 221 ZYMO RESEARCH CORPORATION: DEALS 242
12.1.13 TECAN TRADING AG 243
TABLE 222 TECAN TRADING AG: BUSINESS OVERVIEW 243
FIGURE 43 TECAN TRADING AG: COMPANY SNAPSHOT (2022) 244
12.1.14 INTEGRAGEN SA 246
TABLE 223 INTEGRAGEN SA: BUSINESS OVERVIEW 246
FIGURE 44 INTEGRAGEN SA: COMPANY SNAPSHOT (2022) 246
TABLE 224 INTEGRAGEN SA: DEALS 247
12.1.15 MICROSYNTH AG 248
TABLE 225 MICROSYNTH AG: BUSINESS OVERVIEW 248
12.1.16 DNASTAR, INC. 250
TABLE 226 DNASTAR: BUSINESS OVERVIEW 250
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 251
12.2.1 COSMOSID, INC. 251
12.2.2 MEDGENOME 252
12.2.3 TERRA BIOFORGE (FORMERLY VARIGEN BIOSCIENCES CORPORATION) 252
12.2.4 VERITAS GENETICS 253
12.2.5 BASECLEAR B.V. 253
12.2.6 METAGENOMI 254
12.2.7 COMPUTOMICS 254
12.2.8 NEW ENGLAND BIOLABS 255
12.2.9 INTACT GENOMICS, INC. 258
13 APPENDIX 259
13.1 DISCUSSION GUIDE 259
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 263
13.3 CUSTOMIZATION OPTIONS 265
13.4 RELATED REPORTS 265
13.5 AUTHOR DETAILS 266